Sign In

Gabriel Lopez

Founder and CEO at Synvivia

Gabriel Lopez is the CEO and founder of Synvivia, a synthetic biology company based in Berkeley, California.2 He co-invented the company's foundational technology while pursuing his Ph.D. in Bioengineering and Biomedical Engineering at UC Berkeley.1

Career and Education

Gabriel Lopez founded Synvivia in 2015.14 The company was part of the Y Combinator cohort in 2016.1 Prior to founding Synvivia, Lopez worked at UC Berkeley from 2008 to 2010.5

After completing his Ph.D., Lopez expanded on his doctoral work as a postdoc in the lab of UC Berkeley Professor of Entomology John Anderson, where he developed new protein engineering architectures and workflows.1

Synvivia

Synvivia is a biotechnology company that focuses on:

  1. Optimizing cell behavior for gene therapy manufacturing1
  2. Developing genetically encoded biocontainment technologies1
  3. Applying chemical control over cell behavior to improve biomanufacturing of high-value biopharmaceutical products2

The company's technology was developed at UC Berkeley with grants from the NSF and DARPA. Synvivia's work has been published in ACS Synthetic Biology and featured as an Editor's Choice in Science Magazine.1

Recognition and Funding

Synvivia has received backing from:

  • Y Combinator
  • National Institutes of Health
  • Industrial partnerships1

The company is also part of the California Innovation Fund's portfolio.4

Gabriel Lopez's LinkedIn profile indicates that he has over 500 connections and is based in Berkeley, California.3

Highlights

Synvivia - California Innovation Fund
Apr 16 · The Mercury News
High school football roundup: Deer Valley stuns Freedom, snaps 16-game losing streak - The Mercury News
High school football roundup: Deer Valley stuns Freedom, snaps 16-game losing streak - The Mercury N
Total College Commit List-Latest - goffrugbyreport.com
Gabriel Lopez - SynBioBeta 2018

Related Questions

What inspired Gabriel Lopez to start Synvivia?
How did Gabriel Lopez's work at UC Berkeley influence Synvivia's technology?
What are the main challenges Gabriel Lopez faces as CEO of Synvivia?
How does Synvivia's technology differ from other gene therapy manufacturing methods?
What role did Y Combinator play in the development of Synvivia?
G
Add to my network

Experience

CEO and Founder at Synvivia (June 2016 - Present)
Postdoc at UC Berkeley (June 2015 - May 2016), Ph.D. Student at UC Berkeley (August 2008 - June 2015)

Education

Ph.D. in Bioengineering and Biomedical Engineering from UC Berkeley and University of California, San Francisco (2008 - 2015), B.S. in Cell/Cellular and Molecular Biology and B.A. in Spanish Language and Literature from UC Santa Barbara (2002 - 2007)

Location

Berkeley, California